Skip to content

The diagnostic value of circulating tumor cells and exosomes acquisited from portal venous by endoscopic ultrasound in pancreatic cancer: a prospective clinical study

The diagnostic value of circulating tumor cells and exosomes acquisited from portal venous by endoscopic ultrasound in pancreatic cancer: a prospective clinical study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018331
Enrollment
Unknown
Registered
2018-09-12
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Interventions

Gold Standard:Pathology
tumor&#32
the&#32
expression&#32
of&#32
exosomes.

Sponsors

Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 80 years-old; 2. Suspected pancreatic cancer and referred for EUS-FNA according to patients condition; 3. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who have received adjuvant chemotherapy and other anti-tumor treatment; 2. Severe heart, lung, liver, kidney insufficiency, or severe bleeding disorders, severe coagulopathy or local/systemic infections, other critical illnesses cannot tolerate surgery; 3. Women who are planning to become pregnant or are pregnant or breast-feeding.

Design outcomes

Primary

MeasureTime frame
Circulating Tumor Cell;Exosome;

Countries

China

Contacts

Public ContactYing Lv

Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital

13770755008@126.com+86 13770755008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026